UNSPSC 51283703: Cefbuperazone

This classification denotes a cephalosporin antibiotic with the molecular formula C22H29N9O9S2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier T0785J3X40, chemically known as 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((2-(((4-ethyl-2,3-dioxo-1-piperazinyl)carbonyl)amino)-3-hydroxy-1-oxobutyl)amino)-7-methoxy-3-(((1-methyl-1h-tetrazol-5-yl)thio)methyl)-8-oxo-, (6r-(6alpha,7alpha,7(2r*,3s*)))- but generally known as cefbuperazone, which bears US NIH Compound Identifier 53522.

UNSPSC 51283703 Cefbuperazone is a Commodity code that in recent state and local procurement activity has tagged pharmaceutical supply contracts, though the actual solicitations do not align closely with the code's nominal scope. The recent opportunities identified under this code involve naloxone distribution and safe drug deactivation systems for community health use, as well as antibiotic tablet supply through cooperative purchasing agreements. State and local health departments and county government health authorities are the primary issuing bodies soliciting under this code identifier, though the mismatch between the code name and the products actually being procured suggests either tagging inconsistency in the procurement system or a broader pharmaceutical-supply classification issue within state and local databases.

Geographic activity appears concentrated in Florida and Illinois based on recent postings. Seminole County, Florida issued an IFB on June 30, 2026 (due July 26, 2023 — note the date anomaly in the source) seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, and the Illinois Department of Public Health awarded a piggyback pharmaceutical warehouse contract through the MMCAP Infuse consortium to Chartwell Rx LLC on August 28, 2026 for antibiotic tablets (Doxycycline Hyclate 100mg and Ciprofloxacin Hydrochloride 500mg) valued at $2,999,999.11 over the full contract term including renewal periods. The Illinois opportunity was awarded via an Invitation for Bid process with no set-aside or domestic-product-preference requirements applied. Business development activity under this code should flag the persistent tagging misalignment and treat the actual work scopes — community health pharmaceutical supply and deactivation systems — as the operative procurement focus rather than the code's formal product name.